How Is Chronic Lymphocytic Leukemia Treated?

 

In the early stages, chronic lymphocytic leukemia (CLL) may not need treatment and you may be only observed. Many patients may live their normal life span not needing any treatment. Treatment is generally advised in patients with advanced CLL (Rai stage III-IV), if there is bulky disease (lymph nodes, liver spleen), if they have complications of CLL (infections, immune problems), or if they have significant symptoms caused by CLL, such as fatigue, sweats, fever, weight loss, severe skin itching/lesions, or others.

Specific treatment for CLL will be determined by your physician based on:

  • Your age, overall health, and medical history
  • Extent of the disease
  • Stage of the disease
  • Your tolerance for specific medications, procedures, or therapies
  • Expectations for the course of the disease
  • Your opinion or preference
Treatment may include:
  • Chemotherapy
  • Monoclonal antibodies (Rituxan® [rituximab] or Campath® [alemtuzumab]
  • Treatment for complications, such as infection or anemia
  • Bone marrow transplantation
  • Splenectomy - surgery to remove the spleen
  • Radiation therapy

Click here for more information about CLL.

This content was last modified on August 11, 2007 .
Latest Leukemia News
New study backs solvent, leukemia link

November 18, 2008 — NEW YORK (Reuters Health) - Research from Italy provides new evidence that exposure to the industrial solvent benzene increases a person's risk of developing multiple myeloma.

Modern cancer drugs more likely to get to market

November 14, 2008 — LONDON (Reuters) - Nearly one in five cancer drugs entering development now reach the market, a remarkably good success rate given the high level of failures in other disease areas, British researchers said on Friday.

Bone marrow transplant suppresses AIDS in patient

November 13, 2008 — BERLIN (Reuters) - A bone marrow transplant using stem cells from a donor with natural genetic resistance to the AIDS virus has left an HIV patient free of infection for nearly two years, German researchers.

Select news items provided by Reuters Health